Armistice Capital’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-42,000
| Closed | -$155K | – | 322 |
|
|
2024
Q2 | $155K | Buy |
42,000
+33,000
| +367% | +$122K | ﹤0.01% | 212 |
|
|
2024
Q1 | $118K | Buy |
+9,000
| New | +$118K | ﹤0.01% | 299 |
|
|
2023
Q2 | – | Sell |
-1,498
| Closed | -$241K | – | 273 |
|
|
2023
Q1 | $241K | Buy |
1,498
+798
| +114% | +$128K | ﹤0.01% | 177 |
|
|
2022
Q4 | $257K | Buy |
+700
| New | +$257K | ﹤0.01% | 149 |
|
|
2021
Q3 | – | Hold |
0
| – | -$49K | – | 160 |
|
|
2021
Q2 | – | Hold |
0
| – | -$80K | – | 113 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 107 |
|